Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates

被引:577
作者
Devine, SM
Cobbs, C
Jennings, M
Bartholomew, A
Hoffman, R
机构
[1] Univ Illinois, Coll Med, Hematol Oncol Sect, Chicago, IL 60612 USA
[2] Osiris Therapeut, Baltimore, MD USA
关键词
D O I
10.1182/blood-2002-06-1830
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ex vivo-expanded mesenchymal stem cells (MSCs) were transduced with a green fluorescent protein (GFP) retroviral construct and subsequently infused into 3 adult baboons following lethal total body irradiation and hematopoietic support or without any prior conditioning. To study the long-term fate of these MSCs, necropsies were performed between 9 and 21 months following MSC infusion, and an average of 16 distinct tissues were recovered from each recipient and evaluated for the presence of the GFP transgene in purified genomic DNA by sensitive real-time polymerase chain reaction (PCR). Two baboons received autologous and one allogeneic GFP-transduced MSCs. Both allogeneic and autologous MSCs appeared to distribute in a similar manner. Gastrointestinal tissues harbored high concentrations of transgene per microgram of DNA. Additional tissues including kidney, lung, liver, thymus, and skin were also found to contain relatively high amounts of DNA equivalents. Estimated levels of engraftment in these tissues ranged from 0.1% to 2.7%. The non-conditioned recipient appeared to have less abundant engraftment. These data suggest that MSCs initially distribute broadly following systemic infusion and later may participate in ongoing cellular turnover and replacement in a wide variety of tissues. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:2999 / 3001
页数:3
相关论文
共 19 条
[1]   Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo [J].
Bartholomew, A ;
Patil, S ;
Mackay, A ;
Nelson, M ;
Buyaner, D ;
Hardy, W ;
Mosca, J ;
Sturgeon, C ;
Siatskas, M ;
Mahmud, N ;
Ferrer, K ;
Deans, R ;
Moseley, A ;
Hoffman, R ;
Devine, SM .
HUMAN GENE THERAPY, 2001, 12 (12) :1527-1541
[2]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[3]   Bone marrow stromal stem cells: Nature, biology, and potential applications [J].
Bianco, P ;
Riminucci, M ;
Gronthos, S ;
Robey, PG .
STEM CELLS, 2001, 19 (03) :180-192
[4]   Marrow stromal stem cells [J].
Bianco, P ;
Robey, PG .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (12) :1663-1668
[5]   Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion [J].
Devine, SM ;
Bartholomew, AM ;
Mahmud, N ;
Nelson, M ;
Patil, S ;
Hardy, W ;
Sturgeon, C ;
Hewett, T ;
Chung, T ;
Stock, W ;
Sher, D ;
Weissman, S ;
Ferrer, K ;
Mosca, J ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2001, 29 (02) :244-255
[6]  
Devine SM, 2001, CANCER J, V7, pS76
[7]   Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli [J].
Di Nicola, M ;
Carlo-Stella, C ;
Magni, M ;
Milanesi, M ;
Longoni, PD ;
Matteucci, P ;
Grisanti, S ;
Gianni, AM .
BLOOD, 2002, 99 (10) :3838-3843
[8]   Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta [J].
Horwitz, EM ;
Prockop, DJ ;
Fitzpatrick, LA ;
Koo, WWK ;
Gordon, PL ;
Neel, M ;
Sussman, M ;
Orchard, P ;
Marx, JC ;
Pyeritz, RE ;
Brenner, MK .
NATURE MEDICINE, 1999, 5 (03) :309-313
[9]   Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy [J].
Koç, ON ;
Gerson, SL ;
Cooper, BW ;
Dyhouse, SM ;
Haynesworth, SE ;
Caplan, AI ;
Lazarus, HM .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) :307-316
[10]   Mesenchymal stem cells:: heading into the clinic [J].
Koç, ON ;
Lazarus, HM .
BONE MARROW TRANSPLANTATION, 2001, 27 (03) :235-239